Clinical trial
Mesenchymal Stem Cells in Multiple Sclerosis (MSCIMS)
NCT00395200 · University of Cambridge, Other · Completed
Key facts
| NCT number | NCT00395200 |
|---|---|
| Title | Mesenchymal Stem Cells in Multiple Sclerosis (MSCIMS) |
| Official title | Autologous Adult Human Mesenchymal Stem Cells: a Neuroprotective Therapy for Multiple Sclerosis |
| Acronym | MSCIMS |
| Lead sponsor | University of Cambridge, Other |
| Collaborators | Cambridge University Hospitals NHS Foundation Trust Medical Research Council |
| Status | Completed |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Multiple Sclerosis |
| Intervention type | Procedure |
| Interventions | MSC Treatment |
| Enrollment | 10 |
| Start date | Jul 1, 2008 |
| Primary completion | Dec 1, 2010 |
| Completion | Dec 1, 2010 |
| First posted | Nov 2, 2006 |
| Last update posted | Oct 25, 2011 |
| Countries | United Kingdom |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: